About
Contact & Profiles
A5019164987
Research Areas
- Peptidase Inhibition and Analysis
- Sirtuins and Resveratrol in Medicine
- Adipose Tissue and Metabolism
- Diabetes Treatment and Management
- Chronic Kidney Disease and Diabetes
- Lipid metabolism and biosynthesis
Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences
2024
Chinese University of Hong Kong
2019
10.1007/s13105-024-01024-z
article
EN
Journal of Physiology and Biochemistry
2024-06-10
Diabetic nephropathy (DN) is one of the major causes end-stage renal disease (ESRD), but treatment remains ineffective due to its unclear pathogenesis. The pathogenic role a risk factor C-reactive protein (CRP) has been increasingly recognized in type-2 DN (T2DN). Recently, number studies showed that plasma CRP level can be significantly reduced diabetic patients by dipeptidyl peptidase-4 (DPP4) inhibitor treatment. A better understanding underlying mechanism would uncover novel therapeutic...
10.1016/j.ekir.2019.05.343
article
EN
cc-by-nc-nd
Kidney International Reports
2019-07-01
Coming Soon ...